Back
ESC Premium Access

Future direction for research in drug - eluting stent technology.

Session: Drug - Eluting stent
Topic: PCI / stents: devices and technique
Speaker: Doctor M. Morice (Massy, FR)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Marie-Claude Morice

Cardiovascular Institute Paris-Sud (ICPS), Massy (France)
8 presentations
1 follower

4 more presentations in this session

State of the art in drug eluting stent technology.

Speaker: Professor R. Byrne (Dublin, IE)

Access
Slides
Video
Thumbnail

Ten year clinical outcome of a large registry with unrestricted use of DES

Speaker: Professor R. van Geuns (Nijmegen, NL)

Access
Abstract
Slides
Video
Thumbnail

Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR

Speaker: Professor E. Omerovic (Gothenburg, SE)

Access
Abstract
Thumbnail

Long-term clinical outcomes of biolimus-eluting stents with biodegradable versus bare-metal stents in patients with acute STEMI: 5 Year results of the randomized COMFORTABLE AMI trial.

Speaker: Doctor L. Raber (Bern, CH)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Drug - Eluting stent

Speakers: Doctor M. Morice, Professor R. Byrne, Professor R. van Geuns, Professor E. Omerovic, Doctor L. Raber
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb